VivoSim Labs, Inc. Equity Securities, FV-NI, Gain (Loss)
VivoSim Labs, Inc. (VIVS) reported Equity Securities, FV-NI, Gain (Loss) of $94.00 thousand for the 12-month period ending 2026-03-31, per its 10-K filed 2026-07-14.
Financial Statements › Income Statement › Other Income
us-gaap:EquitySecuritiesFvNiGainLoss · last filed 2026-07-14
- VivoSim Labs, Inc. equity securities, fv-ni, gain (loss) for the quarter ending 2025-03-31 was $0.00.
- VivoSim Labs, Inc. equity securities, fv-ni, gain (loss) for the quarter ending 2024-12-31 was $0.00.
- VivoSim Labs, Inc. equity securities, fv-ni, gain (loss) for the quarter ending 2024-09-30 was $0.00.
- VivoSim Labs, Inc. equity securities, fv-ni, gain (loss) for the quarter ending 2024-06-30 was $0.00, a 100.00% decline year-over-year.
- VivoSim Labs, Inc. equity securities, fv-ni, gain (loss) for fiscal 2026 was $94.00K.
- VivoSim Labs, Inc. equity securities, fv-ni, gain (loss) for fiscal 2025 was $0.00, a 100.00% decline from fiscal 2024.
- VivoSim Labs, Inc. equity securities, fv-ni, gain (loss) for fiscal 2024 was $12.00K, a 58.62% decline from fiscal 2023.
- VivoSim Labs, Inc. equity securities, fv-ni, gain (loss) for fiscal 2023 was $29.00K.
| Period end | Equity Securities, FV-NI, Gain (Loss) 3 month | Equity Securities, FV-NI, Gain (Loss) 6 month | Equity Securities, FV-NI, Gain (Loss) 9 month | Equity Securities, FV-NI, Gain (Loss) 12 month |
|---|---|---|---|---|
| 2026-03-31 | $94.00K 10-K · filed 2026-07-14 | |||
| 2025-03-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-14 | $0.00 derived: sum of 2 quarters · filed 2026-07-14 | $0.00 derived: sum of 3 quarters · filed 2026-07-14 | $0.00 10-K · filed 2026-07-14 |
| 2024-12-31 | $0.00 10-Q · filed 2025-02-19 | $0.00 derived: sum of 2 quarters · filed 2025-02-19 | $0.00 10-Q · filed 2025-02-19 | $0.00 derived: sum of 4 quarters · filed 2025-06-05 |
| 2024-09-30 | $0.00 10-Q · filed 2024-11-08 | $0.00 10-Q · filed 2024-11-08 | $0.00 derived: sum of 3 quarters · filed 2025-06-05 | $0.00 derived: sum of 4 quarters · filed 2025-06-05 |
| 2024-06-30 | $0.00 10-Q · filed 2024-08-05 | $0.00 derived: sum of 2 quarters · filed 2025-06-05 | $0.00 derived: sum of 3 quarters · filed 2025-06-05 | $0.00 derived: sum of 4 quarters · filed 2025-06-05 |
| 2024-03-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-06-05 | $0.00 derived: sum of 2 quarters · filed 2025-06-05 | $0.00 derived: sum of 3 quarters · filed 2025-06-05 | $12.00K 10-K · filed 2025-06-05 |
| 2023-12-31 | $0.00 10-Q · filed 2025-02-19 | $0.00 derived: sum of 2 quarters · filed 2025-02-19 | $12.00K 10-Q · filed 2025-02-19 | $164.00K derived: sum of 4 quarters · filed 2025-02-19 |
| 2023-09-30 | $0.00 10-Q · filed 2024-11-08 | $12.00K 10-Q · filed 2024-11-08 | $164.00K derived: sum of 3 quarters · filed 2024-11-08 | $116.00K derived: sum of 4 quarters · filed 2024-11-08 |
| 2023-06-30 | $12.00K 10-Q · filed 2024-08-05 | $164.00K derived: sum of 2 quarters · filed 2024-08-05 | $116.00K derived: sum of 3 quarters · filed 2024-08-05 | $46.00K derived: sum of 4 quarters · filed 2024-08-05 |
| 2023-03-31 | $152.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-05-31 | $104.00K derived: sum of 2 quarters · filed 2024-05-31 | $34.00K derived: sum of 3 quarters · filed 2024-05-31 | $29.00K 10-K · filed 2024-05-31 |
| 2022-12-31 | -$48.00K 10-Q · filed 2024-02-08 | -$118.00K derived: sum of 2 quarters · filed 2024-02-08 | -$123.00K 10-Q · filed 2024-02-08 | -$123.00K derived: sum of 4 quarters · filed 2024-02-08 |
| 2022-09-30 | -$70.00K 10-Q · filed 2023-11-09 | -$75.00K 10-Q · filed 2023-11-09 | -$75.00K derived: sum of 3 quarters · filed 2023-11-09 | -$75.00K derived: sum of 4 quarters · filed 2023-11-09 |
| 2022-06-30 | -$5.00K 10-Q · filed 2023-08-10 | -$5.00K derived: sum of 2 quarters · filed 2023-08-10 | -$5.00K derived: sum of 3 quarters · filed 2023-08-10 | -$5.00K derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-03-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-07-14 | $0.00 derived: sum of 2 quarters · filed 2023-07-14 | $0.00 derived: sum of 3 quarters · filed 2023-07-14 | $0.00 10-K · filed 2023-07-14 |
| 2021-12-31 | $0.00 10-Q · filed 2023-02-09 | $0.00 derived: sum of 2 quarters · filed 2023-02-09 | $0.00 10-Q · filed 2023-02-09 | |
| 2021-09-30 | $0.00 10-Q · filed 2022-11-10 | $0.00 10-Q · filed 2022-11-10 | ||
| 2021-06-30 | $0.00 10-Q · filed 2022-08-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |